STOCK TITAN

SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) announced that CEO Dr. Jurgi Camblong and CFO Ross Muken will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference. This event will take place on September 12, 2022, at 8:45 a.m. EDT. SOPHiA GENETICS is a cloud-native software company focused on data-driven medicine, utilizing its SOPHiA DDM™ Platform for analyzing complex multimodal data sets. Its solutions are widely used by hospitals, laboratories, and biopharma institutions globally.

Positive
  • None.
Negative
  • None.

BOSTON and LAUSANNE, Switzerland, Sept. 02, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today Chief Executive Officer, Dr. Jurgi Camblong and Chief Financial Officer, Ross Muken will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on Monday, September 12, 2022, at 8:45 a.m. EDT.

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram. Where others see data, we see answers

Investor Contact:
Jennifer Pottage
Head of Investor Relations
ir@sophiagenetics.com

Media Contact:
Kelly Katapodis
Senior Manager, Media & Communications
media@sophiagenetics.com


FAQ

When is the SOPHiA GENETICS fireside chat at the Morgan Stanley Global Healthcare Conference?

The SOPHiA GENETICS fireside chat will take place on September 12, 2022, at 8:45 a.m. EDT.

Who will represent SOPHiA GENETICS at the Morgan Stanley Global Healthcare Conference?

CEO Dr. Jurgi Camblong and CFO Ross Muken will represent SOPHiA GENETICS.

What is SOPHiA GENETICS known for?

SOPHiA GENETICS is known for its cloud-native software and the SOPHiA DDM™ Platform, which aids in data-driven medicine.

How does SOPHiA GENETICS contribute to healthcare?

SOPHiA GENETICS contributes to healthcare by providing data analysis solutions that facilitate insights from complex data.

What is the purpose of the SOPHiA DDM™ Platform?

The SOPHiA DDM™ Platform is designed to analyze multimodal data sets and assist in life sciences research.

SOPHiA GENETICS SA Ordinary Shares

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Stock Data

248.28M
65.38M
5.84%
49.85%
0.02%
Health Information Services
Healthcare
Link
United States of America
Rolle